Trending...
- For Small Business Week: This Math should be Required Reading For Every Business in the Universe! - 110
- Emmy Winning Broadcaster Dave Benz Launches TixScape to Help Fans Find World Cup Deals
- California: Governor Newsom statement on Fifth Circuit ruling restricting access to mifepristone
CASTRO VALLEY, Calif. - Californer -- Veyond Metaverse, the most advanced extended reality (XR) technology platform, is pleased to announce the addition of three new members to its Advisory Board. The new members are Dr. James Snider, John Erickson, and Jim McMenamy. James Snider, a current CEO at Critical Diagnostics, brings unparalleled experience and clinical expertise in the cardiovascular business career spanning three decades. James is a great complement to Veyond Metaverse and adds a unique perspective, given his accomplished cardiovascular IVD and business career.
John Erickson is a dynamic and strategic senior global health care business leader with success-based experience from Fortune 50 to start-ups including Johnson & Johnson, Abbott, Bio-Rad, Nexus Dx, and as a consultant to diabetes, clinical diagnostic, and life science companies. John has been recognized for proven leadership in delivering superior results, developing profitable growth strategies, and building high-performance teams. Additionally, John has been responsible for developing, launching, and managing over three dozen scientific products with cumulative revenues in excess of $4 billion and has raised more than $50 million in investment capital. John's experiential portfolio and business acumen also include strategy development and execution, capital funding, organizational design, and cultural change management, numerous global new product launches, joint venture management, corporate partnerships, product licensing agreements, intellectual property strategy, Digital Health, and Point of Care (POC), and emerging market development expertise. John's experience will be a critical value for Veyond Metaverse.
More on The Californer
Jim McMenamy has spent the last 30+ years focusing primarily on the development and worldwide launch of numerous Human and Veterinary Clinical Diagnostic Test Systems with a specific focus on the Point of Care Marketplace. He has launched dozens of new products in Infectious Diseases, Cancer Markers, Fertility Tests, Drugs of Abuse, etc., both Instrumented and non-Instrumented. He has held leadership positions in Marketing, Sales, Business Development, Corporate Development, and General Management with companies such as Samsung (NexusDx), Becton Dickinson, Quidel, ACON Labs, Alere/Inverness Medical, scil/Henry Schein Animal Health, and diatron/Stratec Corp.
"We are very excited to have James, John, and Jim join our Advisory Board here at Veyond Metaverse! The new advisory board is a great complement to our experienced executive team and adds a unique perspective, given their long and successful business career. All three advisors are a well-known leader in the key areas where Veyond Metaverse is focused, making their appointment a strategic and integral part of our company growth."
— Adam Choe, Co-founder, and CEO, Veyond Metaverse
More on The Californer
About Veyond Metaverse
Veyond Metaverse offers a new and disruptive XR technology to medical education, surgical planning, and training, augmented assisted surgical operations, pharmaceutical, oncology treatment, and diagnosis. Our proprietary communication platform enables global engagement and collaboration seamlessly, creating a more accessible, user-friendly ecosystem by leveraging the most advanced communication capabilities. We seek to improve medical education, surgical training, save patients' lives by enhancing surgery, diagnosis, and expand worldwide access through the proprietary cloud platform. Veyond Metaverse is based in Silicon Valley, CA. Visit www.veyondmetaverse.com
John Erickson is a dynamic and strategic senior global health care business leader with success-based experience from Fortune 50 to start-ups including Johnson & Johnson, Abbott, Bio-Rad, Nexus Dx, and as a consultant to diabetes, clinical diagnostic, and life science companies. John has been recognized for proven leadership in delivering superior results, developing profitable growth strategies, and building high-performance teams. Additionally, John has been responsible for developing, launching, and managing over three dozen scientific products with cumulative revenues in excess of $4 billion and has raised more than $50 million in investment capital. John's experiential portfolio and business acumen also include strategy development and execution, capital funding, organizational design, and cultural change management, numerous global new product launches, joint venture management, corporate partnerships, product licensing agreements, intellectual property strategy, Digital Health, and Point of Care (POC), and emerging market development expertise. John's experience will be a critical value for Veyond Metaverse.
More on The Californer
- Michael Harlow's Ocean Eco-Thriller Blue Planet – Red Tide Now Available for Pre-Order on Amazon
- ICTPBX Released: White-Label, Multi-Tenant Open Source PBX Platform for ITSPs
- 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
- SEEAG's Free "Farm Day Every Day" At Rancho Olivos in Santa Ynez
- Bodega Bay Surprise Proposal Captured at Sunset's Zenith
Jim McMenamy has spent the last 30+ years focusing primarily on the development and worldwide launch of numerous Human and Veterinary Clinical Diagnostic Test Systems with a specific focus on the Point of Care Marketplace. He has launched dozens of new products in Infectious Diseases, Cancer Markers, Fertility Tests, Drugs of Abuse, etc., both Instrumented and non-Instrumented. He has held leadership positions in Marketing, Sales, Business Development, Corporate Development, and General Management with companies such as Samsung (NexusDx), Becton Dickinson, Quidel, ACON Labs, Alere/Inverness Medical, scil/Henry Schein Animal Health, and diatron/Stratec Corp.
"We are very excited to have James, John, and Jim join our Advisory Board here at Veyond Metaverse! The new advisory board is a great complement to our experienced executive team and adds a unique perspective, given their long and successful business career. All three advisors are a well-known leader in the key areas where Veyond Metaverse is focused, making their appointment a strategic and integral part of our company growth."
— Adam Choe, Co-founder, and CEO, Veyond Metaverse
More on The Californer
- Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
- City of Long Beach to Host Community Meeting on Martin Luther King Jr. Park Projects
- Free Critical Illness Claim Calculator Launches to the Public
- Governor Newsom announces $1B in private investment generated through California Competes Tax Credits, driving business expansion in key industry sectors
- TeleIQ Launches Partner Program Offering Recurring Revenue with AI Phone Automation
About Veyond Metaverse
Veyond Metaverse offers a new and disruptive XR technology to medical education, surgical planning, and training, augmented assisted surgical operations, pharmaceutical, oncology treatment, and diagnosis. Our proprietary communication platform enables global engagement and collaboration seamlessly, creating a more accessible, user-friendly ecosystem by leveraging the most advanced communication capabilities. We seek to improve medical education, surgical training, save patients' lives by enhancing surgery, diagnosis, and expand worldwide access through the proprietary cloud platform. Veyond Metaverse is based in Silicon Valley, CA. Visit www.veyondmetaverse.com
Source: Veyond Metaverse
Filed Under: Medical
0 Comments
Latest on The Californer
- mBOLDen Change Launches Move My DAF to Help Donors Find Values-Aligned DAF Sponsors
- CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
- BTR: i2 Group Launches i2 Amplify, a Community Platform for Intelligence Professionals Worldwide
- Registration Now Available for Dodgers Dreamteam Program in Long Beach for Local Youth
- 555 Vitae Joins American Racing as Official Wellness Partner for 2026 MotoGP World Championship
- LAX Van Rentals Expands One-Way Service to Las Vegas and San Diego for Group Travelers
- L.A. Watts Summer Games Announces Free Pelé Tribute Event at Magic Johnson Park
- California: Governor, First Partner statement on the passing of Doris Fisher
- Long Beach: City to Celebrate Small Business and Economic Development Weeks in May
- From Small Stages to Big Dreams: "Zero to 100 Open Mics" To Chronicle the Comedy Grind Across America
- Jon Henderson Brings California 2.0 To Lafayette For Community Conversation On The State's Future
- New Research Confirms that TCA Venture Group Portfolio Companies with Member Board Representation Perform Dramatically Better in Returns, Exits & MOIC
- SUMOFIBER Fuels Explosive Growth With netElastic vBNG
- NRx Pharmaceuticals (N A S D A Q: NRXP) Accelerates Into National Spotlight as Manufacturing Launch, Federal Policy & AI-Driven Breakthroughs Converge
- Expanding Into High-Margin Battery Recycling With Black Mass Strategy plus Scaling AI Infrastructure & Global Supply Chain Platform: N A S D A Q: MWYN
- Long-Distance Couples Spend Nearly $7,000 on Travel Before Moving In Together, New Mayflower Research Finds
- LegalEng Consulting Group Appoints Mary O'Carroll as Chief Executive Officer
- imggpt Launches AI-Powered GPT Image Generator and Photo Editor for Creative Teams
- Intuitive Flow Systems Launches Mokēd Meditation Whistle
- Plaza Mexico celebrates Mother's Day